Plasma and urinary matrix metalloproteinase-9 as a marker for detection of nephropathy in type 2 diabetic patients

Journal Title: International Journal of Medical Science and Public Health - Year 2015, Vol 4, Issue 10

Abstract

Background: Diabetic nephropathy (DN) is a serious complication in diabetes and now it has become the most common cause of end-stage renal disease (ESRD). Development of diabetic nephropathy is characterized by a thickening of the glomerular basement membrane and expansion of extracellular matrix proteins in the mesangial and tubulointerstitial areas, followed ultimately by progression to glomerular sclerosis and tubulointerstitial atrophy and fibrosis associated with renal dysfunction. Several growth factors, signaling pathways, along with hyperglycemia affect ECM synthesis and turnover in DN. Objective: The aim of this study was to evaluate the significance of plasma and urinary matrix metalloproteinase-9 (MMP-9) in type 2 diabetic patients with microalbuminuria. Materials and Methods: Fifty type 2 diabetic patients with more than 5 year diabetic duration in the age group of 35–60 years were selected for this study and 25 age-matched healthy individuals were selected as a control group. Plasma and urinary levels of MMP-9 were assessed by ELISA method and microalbumin by turbilatex method. Results: The plasma and urinary MMP-9 levels are significantly elevated in type 2 DM with microalbuminuria compared to normoalbuminuric type 2DM and also there is significant elevation observed in normoalbuminuric type 2 DM compared to controls. Conclusion: Plasma and urinary MMP-9 might be useful to detect early stages of nephropathy in T2DM patients. Hence, measurement of plasma and urinary MMP-9 could be useful diagnostic markers for the assessment of renal changes in type 2 diabetic patients even before the appearance of microalbuminuria.

Authors and Affiliations

K Balu Mahendran, S Sethupathy, KK Perumal, R Inmozhi, K Santha

Keywords

Related Articles

Hepatitis E virus: Seroprevalence and associated factors in acute viral hepatitis during pregnancy

Background: Acute viral hepatitis (AVH) is defined as those cases which have acute self-limited disease and a serum aspartate aminotransferase elevation of at least 5-fold or clinical jaundice or both. Hepatitis E virus...

Impact of sleep quality and general health on academic performance

Background: Sleep has many important effects on the human body. One of its most important effects is on one’s memory, where it plays a role in stabilizing perceived information and facilitating generalized knowledge. Obj...

Assessment of knowledge practice gap regarding sanitary toilet - A hospital based cross-sectional study

Background: Lack of safe drinking water, the absence of basic sanitation and hygienic practices is associated with high morbidity and mortality from excreta-related diseases. Different sanitation programs were failed bec...

Prevalence of self-reported diabetes mellitus in an urban population

Background: Noncommunicable diseases (NCDs) are now becoming major public health issues in developing and developed countries. Type 2 diabetes mellitus, being a part of the NCD group, is also showing an upward trend...

Histopathological analysis of non-neoplastic lesions of ovary: A study at tertiary care hospital in western region of India

Background: Ovarian lesions being asymptomatic in nature and very difficult to distinguish between benign or malignant by radiology or clinically, histopathological analysis becomes necessary. Nowadays, due to changing l...

Download PDF file
  • EP ID EP111926
  • DOI 10.5455/ijmsph.2015.09042015292
  • Views 84
  • Downloads 0

How To Cite

K Balu Mahendran, S Sethupathy, KK Perumal, R Inmozhi, K Santha (2015). Plasma and urinary matrix metalloproteinase-9 as a marker for detection of nephropathy in type 2 diabetic patients. International Journal of Medical Science and Public Health, 4(10), 1409-1413. https://europub.co.uk/articles/-A-111926